Cameron Sehl is a healthcare entrepreneur passionate about building companies that expand access to care. He began his career as the co-founder of Symbi Medical, a healthcare software company focused on care navigation in diagnostics. Bootstrapped out of university, Symbi grew into an 11-person team and was acquired in 2021.
Following the acquisition, Cameron joined Blue Charm Adherence, where he helped transform the company into a leading real-world data provider for life sciences. He launched programs in respiratory, neurology, and immunology—most notably building Canada’s largest prospective observational asthma study, which enrolled more than 2,000 patients in its first year.
Today, Cameron advises and invests in ventures across oncology, diagnostics, and patient access, helping bring new healthcare technologies to patients faster.
Originally from Ottawa, he studied economics at St. Francis Xavier University, worked internationally in Hong Kong, India, and the UK, and now lives in Boston with his wife.
